1 |
Tozadenant |
Tozadenant |
1件: D10174 D10174 💬 |
ADORA2A 1件: ADORA2A 💬 |
Alcoholism 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 1件: 6 💬 |
2 |
Tozadenant (syn115) 120 mg bid |
Tozadenant |
1件: D10174 D10174 💬 |
ADORA2A 1件: ADORA2A 💬 |
Alcoholism 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 1件: 6 💬 |
3 |
Tozadenant (syn115) 180 mg bid |
Tozadenant |
1件: D10174 D10174 💬 |
ADORA2A 1件: ADORA2A 💬 |
Alcoholism 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 1件: 6 💬 |
4 |
Tozadenant (syn115) 240 mg bid |
Tozadenant |
1件: D10174 D10174 💬 |
ADORA2A 1件: ADORA2A 💬 |
Alcoholism 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 1件: 6 💬 |
5 |
Tozadenant (syn115) 60 mg bid |
Tozadenant |
1件: D10174 D10174 💬 |
ADORA2A 1件: ADORA2A 💬 |
Alcoholism 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 1件: 6 💬 |